Loading company…
Sunrise develops home testing technology and digital tools for diagnosing sleep apnea.
Founded in 2015 in Belgium, Sunrise develops a compact sensor and digital reporting platform for home diagnosis of obstructive sleep apnea. Its technology is FDA De Novo approved and recommended by NICE. In September 2025, it raised USD 29 million, led by Eurazeo, with new and returning investors participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in